Drug intelligence / Profile preview

SCOCVAC

Development stage: Unknown
Lead developer: Foshan Standard Bio-tech
Modality: Vaccines & Immunotherapeutics
Administration: Oral

Overview

**SCOCVAC** is a proprietary veterinary live coccidiosis vaccine family for chickens developed and manufactured by Foshan Standard Bio-tech. The brand includes live attenuated coccidial vaccine presentations, including trivalent and quadrivalent products, intended to induce protective active immunity against avian coccidiosis caused by *Eimeria* parasites. Foshan Standard Bio-tech obtained marketing authorization for SCOCVAC in Vietnam in 2014, and recent commercial documentation identifies SCOCVAC 4 as a live quadrivalent chicken coccidiosis vaccine manufactured by the company. ([en.shouyao.com](https://en.shouyao.com/))

Brand names: SCOCVAC

Beyond the preview

Go deeper on SCOCVAC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCOCVAC.

Explore the full profile